The Journal of Nutrition, Health and Aging (Mar 2024)
Effectiveness of an intermittent fasting diet versus regular diet on fat loss in overweight and obese middle-aged and elderly people without metabolic disease: a systematic review and meta-analysis of randomized controlled trials
Abstract
Objective: As the number of adults aged over 40 with obesity increases dramatically, intermittent fasting interventions (IF) may help them to lose fat and weight. This systematic review investigated the most recent research on the effects of intermittent fasting and a regular diet on body composition and lipids in adults aged over 40 with obesity without the metabolic disease. Data sources: Randomized controlled trials (RCTs) on IF on adults aged over 40 with obesity were retrieved from PubMed, Web of Science, EBSCO, China Knowledge Network (CNKI), VIP database, Wanfang database with the experimental group using IF and the control group using a regular diet. Revman was used for meta-analysis. Effect sizes are expressed as weighted mean differences (WMD) and 95% confidence intervals (CI). Study selection: A total of 9 articles of randomised controlled trials that met the requirements were screened for inclusion. Studies typically lasted 2–6 weeks. The experimental population was aged 42–66 years, with a BMI range of 25.7−35 kg/m2. Synthesis: A total of 9 RCTs were included. meta-analysis showed that body weight (MD: −2.05 kg; 95% CI (−3.84, −0.27); p = 0.02), BMI (MD: −0.73 kg/m2; 95% CI (−1.05, −0.41); p < 0.001), fat mass (MD: −2.14 kg; 95% CI (−3.81, 0.47); p = 0.01), and TG (MD = −0.32 mmol/L, 95% CI (−0.50, −0.15, p < 0.001) were significantly lower in the experimental group than in the control group. No significant reduction in lean body mass (MD: −0.31 kg; 95% CI (−0.96, 0.34); p = 0.35). Conclusion: IF had a reduction in body weight, BMI, fat mass, and TG in adults aged over 40 with obesity without metabolic disease compared to RD, and IF did not cause a significant decrease in lean body mass, which suggests healthy and effective fat loss. However, more long-term and high-quality trials are needed to reach definitive conclusions.